Latest updates for Artlx
Fresh curated links around ARTLX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Artisan Value Fund Q1 2026 Commentary
- Artisan Value Fund Q1 2026 Portfolio Activity
- Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow
cafepharma.com
/7 hours ago
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
seekingalpha.com
/4 weeks ago
Telix Pharmaceuticals Limited (TLX) Discusses Advances in PSMA Therapy and Insights from the OPTIMAL-PSMA Trial with TLX...
seekingalpha.com
/3 weeks ago
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript
seekingalpha.com
/3 weeks ago
Arcutis Biotherapeutics, Inc. (ARQT) Q1 2026 Earnings Call Transcript
fool.com
/2 weeks ago
Lumexa (LMRI) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateTuesday, May 12, 2026 at 5 p.m. ET Call participantsChief Executive Officer — Caitlin ZullaChief Financial Officer — J. Anthony MartinTakeawaysC...
fool.com
/1 week ago
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding
Artivion delivers advanced cardiovascular and vascular solutions to healthcare providers worldwide through its proprietary medical devices.
seekingalpha.com
/2 weeks ago
Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
finance.yahoo.com
/1 week ago
Astera Labs (ALAB) Hits All-Time High on Bullish Rating, PT Upside
seekingalpha.com
/3 weeks ago
ARN Media Limited (ARNMF) Shareholder/Analyst Call Transcript
seekingalpha.com
/4 weeks ago
Alterity Therapeutics Limited (ATHE) Discusses Phase II Data and Development Strategy for ATH434 in Multiple System Atro...
fool.com
/1 week ago
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.
seekingalpha.com
/1 week ago
Astera Labs, Inc. (ALAB) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Tran...
seekingalpha.com
/1 month ago
MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerostomia and Commercial...
seekingalpha.com
/1 month ago
Allogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line...
seekingalpha.com
/1 month ago
LSI Industries Inc. 2026 Q3 - Results - Earnings Call Presentation
fool.com
/3 weeks ago
Amylyx (AMLX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 7, 2026 at 8 a.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Justin KleeCo-Chief Executive Officer — Joshua CohenChief Commer...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Artlx
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source